Program Legend: Hebrew Networking Event English Scheduled Break WEDNESDAY, JANUARY 08, 2020 POST-GRADUATE DAY 14:00-14:30 Light Buffet Lunch (Exhibition Area) HALL B HALL A SESSION 1 | Treat to target in CD-define your target SESSION 2 | Advances in Clinical Nutrition – Thinking Outside of the “Lunch 14:30-15:45 14:30-15:45 Sponsored by Takeda Box” Chairs: Revital Kariv, Tel Aviv Sourasky Medical Center and Irit Avni Biron, Rabin Chairs: Liat Deutsch, Tel Aviv Sourasky Medical Center and Sigal Frishman, Rabin Medical Center Medical Center 14:30-14:50 Complete Remission- How Deep Is Enough?: Ayal Hirsch, Tel Aviv Sourasky 14:30-14:55 Nutrigenetics - basic and practical concepts: Ruth Birk, Ariel University Medical Center 14:55-15:03 Abstract 3 14:50-15:10 Perianal Fistulas-Do We See The Light At The End Of The Tunnel?: Ian White, Milk derived exosomes has a therapeutic effect on experimental colitis: Rabin Medical Center and Doron Schwartz, Soroka Medical Center Regina Golan-Gerstl, Hadassah Medical Center 15:10-15:30 PROMs In IBD-Ready For Clinical Practice?: Mati Waterman, Rambam Health 15:03-15:11 Abstract 4 Care Campus Characteristics of patients referred for investigation of reflux: Yishai Ron, Tel Aviv Sourasky Medical Center 15:30-15:38 Abstract 1 Vedolizumab has similar efficacy and safety rates in young and elderly 15:11-15:19 Abstract 5 patients- a binational, multicenter, retrospective case-control study: Endoscopic gastro-jejunal anastomotic reduction after bariatric surgery Nathaniel Aviv Cohen, Tel Aviv University improves intractable dumping syndrome: Relly Reicher, Sourasky Medical Center 15:38-15:46 Abstract 2 a4β7 receptor occupancy by vedolizumab at trough time-point occurs at the 15:19-15:44 Intestinal transplantations: Eviatar Nesher, Rabin Medical Center membranal level and is not associated with endoscopic healing in ibd patients: Shomron Ben-Horin, Sheba Medical Center 15:45-16:05 Coffee Break (Exhibition Area) SESSION 3 | Malignancy Precision – Immunology, Genetics, and SESSION 4 | From epidemiology to Technology- Updates in 16:05-17:20 16:05-17:20 Surveillance Neurogastroenterology Chairs: Zohar Levi, Rabin Medical Center and Elizabeth Half, Rambam Health Care Chairs: Ram Dickman, Rabin Medical Center and Roy Dekel, Tel Aviv Sourasky Campus Medical Center 16:05-16:25 Appropriate surveillance intervals tailored by gene and the potential role of 16:05-16:30 Gastroparesis and functional dyspepsia: one and one equal one?: Yehuda enhanced endoscopy in Lynch Syndrome – the post graduate course talk: Uri Ringel, Meir Medical Center Ladabaum, Stanford University School of Medicine 16:30-16:50 EndoFLIP- The new player in esophageal motility testing: Daniel Pohl, 16:25-16:33 Abstract 6 University Hospital Zurich Proteomics portraits the immune landscape of msi-h colorectal tumors: Elez Vainer, Hadassah Medical Center 16:50-16:58 Abstract 8 Volumetric rectal sensation testing: is it clinically relevant? Results from a 16:33-16:58 Immunotherapy of cancer, successes, failures, and challenges: Ilan Volovitz, large patient cohort: Yoav Mazor, Rambam Health Care Campus Tel Aviv Sourasky Medical Center 16:58-17:18 IBS Global Survey: Ami Sperber, Ben-Gurion University of the Negev 16:58-17:06 Abstract 7 Juvenile polyposis syndrome in israel is associated with a high mutation detection rate: Lior Katz, Hadassah Medical Center 17:06-17:26 Current genetic analysis in colorectal cancer: Somatic and germline mutations: Fred Menko, Amsterdam University Medical Center 17:20-17:30 Technical Break HALL B 17:30-18:46 SESSION 5 | Double trouble: Cancer in IBD and IBD in Cancer Chairs: Rami Eliakim, Sheba Medical Center and David Rubin, University of Chicago 17:30-17:50 Advances in Dysplasia detection and management 2020: Ofer Ben Bassat, Barzilai University Medical Center 17:50-17:58 Abstract 9 Effectiveness of dose escalation in Crohn`s disease patients with insufficient response to standard-dose subcutaneous ustekinumab maintenance therapy - a multicenter European cohort study: Uri Kopylov, Tel Aviv University 17:58-18:18 Checkpoint inhibitor and colitis, lessons for IBD: Dror Shouval, Sheba Medical Center 18:18-18:26 Abstract 10 Thromboembolic events in hospitalized patients with inflammatory bowel disease – a large tertiary hospital experience: Asaf Levartovsky, Sheba Medical Center 18:26-18:46 The IBD patient with current/previous cancer: Hagar Banai, Rabin Medical Center and Lior Katz, Hadassah Medical Center 18:46 Drinks & Mingling (Exhibition Area) THURSDAY, JANUARY 09, 2020 07:30-08:30 Light Breakfast and Gathering (Exhibition Area) HALL B 08:30-10:15 SESSION 6 | Opening Session Chairs: Iris Dotan, Rabin Medical Center and Haim Shirin, Shamir Medical Center 08:30-08:45 Opening remarks: Iris Dotan, Rabin Medical Center 08:45-09:15 Positioning of old and new therapies in IBD- personalized decision making: David Rubin, University of Chicago* 09:15-09:45 CRC screening and post polypectomy surveillance strategies, updates and personalized screening: Uri Ladabaum, Stanford University School of Medicine 09:45-10:15 Targeting aging as a reversible disease: Shai Efrati, Shamir Medical Center *Sponsored by Pfizer 10:15-10:45 Coffee Break (Exhibition Area) HALL B HALL A HALL C HALL D SESSION 7 | Updates in Liver SESSION 8 | Performance אחיות | SESSION 10 10:45-12:15 אדמיניסטרציה | SESSION 9 10:45-12:15 10:45-12:15 10:45-12:15 and esophageal disease from Tests to Practice Chairs: Cheli Levin, Assuta Medical תניר ציון, מרכז רפואי רבין :Chairs: Rifaat Safadi, Hadassah Chairs: Ian Gralnek, HaEmek Chairs Medical Center and Haia Medical Center and Tova Center and Dganit Daniel Fainguelernt, Meir Medical Rainis, Bnai Zion Medical Avdar, Hadasssah Medical Center Center Center Updates and Innovations from 10:45-11:00 דברי פתיחה: איריס דותן, מרכז How to simplify treatment of 10:45-11:10 Investigating 10:45-10:55 10:45-11:10 ,ESGENA: Yuri Gurielm רפואי רבין HCV to the way of Gastroenterology patients elimination: Eli Zuckerman, for Pancreatic Exocrine Rambam Health Care Campus מטופלות מהמגזרים השונים Carmel Medical Center* Insufficiency: Miroslav 10:55-11:10 Transesophageal EUS-guided 11:00-11:15 בחברה הישראלית: אריאלה Vujasinovic, Karolinska coil: Violeta Gabovich, Rabin שטרית, מרכז רפואי שערי צדק **Abstract 11 University Hospital 11:10-11:18 Characterization of HDV, Medical Center דם סמוי בצואה: עפרה שרעבי, HBsAg and ALT kinetics under 11:10-11:18 Abstract 14 11:10-11:25 ESD: Amir Klein, Rambam 11:15-11:30 מרכז רפואי קפלן :Peginterferon-Lambda Premium non nocere Monotherapy: The Phase 2 endoscopic biliary stents for Health Care Campus קפסולה אנדוסקופית: עירית LIMT Study: David Yardeni, cholangitis complication 11:25-11:40 Management Endoscopic of 11:30-11:45 אבני, מרכז רפואי רבין Soroka Medical Center choledocholithiasis in the elderly are safe and can be Obesity: Steven Shamah, Rabin Medical Center תזונה כטיפול משלים ברפואה Provocation tests in left for up to 25 months: 11:40-11:55 11:18-11:33 המודרנית: ליהי גודני, מרכז esophageal motility: Why, Anas Kadah, Galilee Medical Should we always need to take 11:45-12:00 רפואי רבין which and when to use: Amir Center Mari, Nazareth Hospital preventive steps?: Shulamit לוגיסטיקה, חזון וחידושים: 11:18-11:33 ERCP 2020- Indications and 11:55-12:10 Monitin, Soroka Medical רויטל קריב, סוראסקי מרכז 11:33-11:41 Abstract 12 complications: Marianna Center רפואי תל אביב Lower vedolizumab trough Arvanitakis, ERCP levels before interval 12:00-12:15 “Holding it inside” isn’t the shortening are not predictive 11:33-11:41 Abstract 15 solution: Leonid Shpoker, Bnai of success of the intervention: Endoscopy and gender, Zion Medical Center Shomron Ben-Horin, Sheba similarities and differences: Medical Center Naim Abu Freha, Soroka Medical Center 11:41-11:49 Abstract 13 Neurtophil to lymphocyte 11:41-12:15 Better Endoscopic Training & ratio predicts progression to Practice – Tips and Tricks- high grade dysplasia and Ian Gralnek interviewing: esophageal adenocarcinoma Harold Jacob, Hadassah in patients with Barrett`s Medical Center, Donald esophagus: Noam Peleg, MacIntosh, Canada and Rabin Medical Center Jonathan Cohen, Lenox Hill Hospital *Sponsored by Gilead **Sponsored by Abbot 11:49-12:14 Eosinophilic Oesophagitis – A common Disease, new treatment options: Stephen Attwood, Durham University* 12:15-13:00 Lunch Break (Exhibition Area) SESSION 12 | The Fatty SESSION 11| Burning ואדמיניסטרציה | Liver & Marilyn Monroe: Is SESSION 13 13:00-14:15 questions in IBD 13:00-14:15 13:00-14:15 אחיות a Treatment for NASH Sponsored by Janssen Finally on the Horizon? Chairs: Ariela Shitrit, Shaare Zedek Chairs: Gil Ben Yakov, Sheba Chairs: Medical Center and Adar Medical Center and Michal Zinger, Hadassah Medical Cohen, Rabin Medical Center Center איך להיות מאושר במאה ה- Mechanisms of molecular 13:00-13:15 Advances in PBC and PSC: 13:00-14:15 :?21 13:00-13:30 אייל דורון, המרז הבינתחומי, resistance and predictors of Ehud Zigmond, Tel Aviv הרצליה ואוניברסיטת חיפה response to biological Sourasky Medical Center therapy in IBD: Raja Atreya, University Hospital Erlangen, 13:15-13:23 Abstract 18 Germany Acute or recent portal vein thrombosis in cirrhosis 13:30-14:00 Immunology and microbiome predicts a hidden or in IBD patients: Nitsan upcoming diagnosis of Maharshak, Tel Aviv Sourasky hepatocellular carcinoma: Medical Center Rifaat Safadi, Hadassah Medical Center 14:00-14:08 Abstract 16 Multi-omics analysis reveals 13:23-13:31 Abstract 19 specific bio-geograohical and Anti-mitochondrial functional characteristics in antibodies